{"i": ["Tranexamic Acid"], "o": []}
{"i": [], "o": []}
{"i": [], "o": []}
{"i": ["Tranexamic acid"], "o": ["total blood loss ."]}
{"i": ["unilateral / bilateral cemented TKA using combined spinal and epidural anaesthesia"], "o": []}
{"i": ["tranexamic acid", "placebo"], "o": []}
{"i": [], "o": []}
{"i": [], "o": ["postoperative blood loss , transfusion requirement , cost effectiveness and complications"]}
{"i": [], "o": []}
{"i": ["placebo"], "o": ["mean volume of drainage fluid"]}
{"i": ["tranexamic acid ."], "o": []}
{"i": [], "o": []}
{"i": ["PRBC", "tranexamic acid"], "o": []}
{"i": [], "o": []}
{"i": [], "o": ["deep vein thrombosis ."]}
{"i": ["Tranexamic acid"], "o": ["total blood loss", "blood transfusion ."]}
{"i": [], "o": []}
{"i": ["Tranexamic acid"], "o": ["total blood loss ."]}
{"i": ["unilateral / bilateral cemented TKA using combined spinal and epidural anaesthesia"], "o": []}
{"i": ["tranexamic acid", "placebo"], "o": []}
{"i": [], "o": []}
{"i": [], "o": ["postoperative blood loss , transfusion requirement , cost effectiveness and complications"]}
{"i": [], "o": []}
{"i": ["placebo"], "o": ["mean volume of drainage fluid"]}
{"i": ["tranexamic acid ."], "o": []}
{"i": [], "o": []}
{"i": ["PRBC", "tranexamic acid"], "o": []}
{"i": [], "o": []}
{"i": [], "o": ["deep vein thrombosis ."]}
{"i": ["Tranexamic acid"], "o": ["total blood loss", "blood transfusion ."]}
{"i": [], "o": []}
{"i": [], "o": []}
{"i": [], "o": []}
{"i": [], "o": []}
{"i": [], "o": []}
{"i": ["Tranexamic acid"], "o": []}
{"i": [], "o": []}
{"i": ["tranexamic acid ( TAX )"], "o": ["blood loss and postoperative blood transfusions"]}
{"i": ["placebo controlled"], "o": []}
{"i": ["midazolam , pethidine , propofol"], "o": []}
{"i": ["B / L TKR", "U / L TKR patients received NS Group CB", "B / L TKR patients received TAX", "metoclopramide", "U / L TKR patients received TAX Group TB", "oral ranitidine 150 mg , alprazolam"], "o": []}
{"i": [], "o": ["electrocardiography ( ECG ), pulse oximetry ; end tidal carbon dioxide , core temperature through nasal probe and non invasive blood pressure monitoring ."]}
{"i": [], "o": []}
{"i": ["placebo"], "o": []}
{"i": ["Tranexamic acid"], "o": []}
{"i": [], "o": []}
{"i": ["equivalent volume of physiologic saline ."], "o": []}
{"i": ["Pneumatic tourniquet"], "o": []}
{"i": [], "o": []}
{"i": [], "o": ["Intraoperative blood losses"]}
{"i": [], "o": ["Postoperative blood losses", "wound drainage"]}
{"i": ["pentastarch", "Ringer ' s lactate"], "o": ["blood losses"]}
{"i": ["leuco depleted allogenic packed red blood cells ."], "o": []}
{"i": [], "o": ["intraoperative and postoperative blood losses"]}
{"i": [], "o": ["tourniquet time and pressure , length of surgery , mean arterial blood pressure maintained during surgery and minimal core temperature achieved ."]}
{"i": [], "o": []}
{"i": ["0 . 125 % bupivacaine with clonidine"], "o": ["Post operative pain"]}
{"i": [], "o": ["Hemoglobin concentration , platelet count ; coagulation profile and renal function tests"]}
{"i": [], "o": []}
{"i": [], "o": []}
{"i": [], "o": []}
{"i": [], "o": ["core temperature ."]}
{"i": [], "o": []}
{"i": ["TAX"], "o": ["blood loss"]}
{"i": [], "o": []}
{"i": [], "o": []}
{"i": ["tranexamic acid"], "o": []}
{"i": [], "o": ["Fall in hemoglobin concentration"]}
{"i": [], "o": []}
{"i": [], "o": ["biochemical evidence of coagulation abnormality .", "clinical evidence of deep vein thrombosis"]}
{"i": [], "o": ["Intraoperative hypotension requiring treat ment"]}
{"i": ["tranexamic acid"], "o": ["blood loss", "blood transfusion"]}
{"i": ["Tranexamic acid ( 1 , 4 - amino - carboxylic acid )", "epsilon aminocaproic acid ( EACA )."], "o": []}
{"i": [], "o": []}
{"i": [], "o": []}
{"i": [], "o": []}
{"i": ["tranexamic acid"], "o": []}
{"i": ["tranexamic acid"], "o": []}
{"i": ["tranexamic acid"], "o": []}
{"i": ["LMWH"], "o": []}
{"i": [], "o": ["fibrinolytic response"]}
{"i": [], "o": ["post - traumatic fibrinolysis"]}
{"i": ["tranexamic acid"], "o": ["blood loss"]}
{"i": [], "o": ["blood loss"]}
{"i": [], "o": ["postoperative blood transfusions"]}
{"i": [], "o": []}
{"i": [], "o": []}
{"i": [], "o": []}
{"i": ["control ( hip and knee replacement ),", "tranexamic acid"], "o": []}
{"i": ["tranexamic acid"], "o": ["total amount of blood lost during perioperative", "allogenic blood transfusion"]}
{"i": [], "o": []}
{"i": ["tranexamic acid"], "o": ["blood loss", "postoperative blood transfusion"]}
{"i": ["tranexamic acid", "placebo"], "o": ["total number of transfused units"]}
{"i": ["tranexamic acid"], "o": []}
{"i": [], "o": []}
{"i": [], "o": []}
{"i": ["tranexamic acid"], "o": []}
{"i": [], "o": []}
{"i": [], "o": []}
{"i": [], "o": []}
{"i": ["tranexamic acid"], "o": ["of blood saved", "Total cost of blood"]}
{"i": [], "o": ["immediate transfusion reactions , transmission of infectious agents and disturbances of the immune system"]}
{"i": ["Tranexamic acid", "TXA"], "o": ["perioperative bleeding", "blood transfusion requirement"]}
